TreeWAS – Variant ID: rs139255058

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
J18.9 Pneumonia, unspecified	0.000	0.990	0.010
J18 Pneumonia, organism unspecified	0.000	0.993	0.007
J18.1 Lobar pneumonia, unspecified	0.000	0.994	0.006
J18.0 Bronchopneumonia, unspecified	0.000	0.995	0.005
J18.8 Other pneumonia, organism unspecified	0.000	0.995	0.005
J18.2 Hypostatic pneumonia, unspecified	0.000	0.995	0.005
J09-J18 Influenza and pneumonia	0.000	0.996	0.003
J30.1 Allergic rhinitis due to pollen	0.004	0.996	0.000
I73.9 Peripheral vascular disease, unspecified	0.000	0.997	0.003
J38.3 Other diseases of vocal cords	0.003	0.997	0.000
A08.4 Viral intestinal infection, unspecified	0.000	0.997	0.003
M51.2 Other specified intervertebral disk displacement	0.003	0.997	0.000
J13 Pneumonia due to Streptococcus pneumoniae	0.000	0.997	0.003
J17 Pneumonia in diseases classified elsewhere	0.000	0.997	0.003
J16 Pneumonia due to other infectious organisms, not elsewhere classified	0.000	0.997	0.003
J15 Bacterial pneumonia, not elsewhere classified	0.000	0.997	0.003
J12 Viral pneumonia, not elsewhere classified	0.000	0.997	0.003
J11 Influenza, virus not identified	0.000	0.997	0.003
J10 Influenza due to identified influenza virus	0.000	0.997	0.003
J14 Pneumonia due to Haemophilus influenzae	0.000	0.997	0.003
J09 Influenza due to certain identified influenza virus	0.000	0.997	0.003
J30 Vasomotor and allergic rhinitis	0.003	0.997	0.000
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)	0.000	0.997	0.003
W19.9 Unspecified place	0.000	0.997	0.003
M54.59 Low back pain (Site unspecified)	0.003	0.997	0.000
J38 Diseases of vocal cords and larynx, not elsewhere classified	0.003	0.997	0.000
H25.1 Senile nuclear cataract	0.003	0.997	0.000
Y43.3 Other antineoplastic drugs	0.003	0.997	0.000
J34.3 Hypertrophy of nasal turbinates	0.003	0.997	0.000
N95.0 Postmenopausal bleeding	0.000	0.997	0.003
M54.5 Low back pain	0.002	0.997	0.000
C50.8 Overlapping lesion of breast	0.002	0.998	0.000
J90 Pleural effusion, not elsewhere classified	0.000	0.998	0.002
M54.39 Sciatica (Site unspecified)	0.002	0.998	0.000
C50 Malignant neoplasm of breast	0.002	0.998	0.000
J10.8 Influenza with other manifestations, influenza virus identified	0.000	0.998	0.002
J10.1 Influenza with other respiratory manifestations, influenza virus identified	0.000	0.998	0.002
J10.0 Influenza with pneumonia, influenza virus identified	0.000	0.998	0.002
J11.8 Influenza with other manifestations, virus not identified	0.000	0.998	0.002
J11.1 Influenza with other respiratory manifestations, virus not identified	0.000	0.998	0.002
J11.0 Influenza with pneumonia, virus not identified	0.000	0.998	0.002
J12.9 Viral pneumonia, unspecified	0.000	0.998	0.002
J12.8 Other viral pneumonia	0.000	0.998	0.002
J12.3 Human metapneumovirus pneumonia	0.000	0.998	0.002
J12.2 Parainfluenza virus pneumonia	0.000	0.998	0.002
J12.1 Respiratory syncytial virus pneumonia	0.000	0.998	0.002
J12.0 Adenoviral pneumonia	0.000	0.998	0.002
J15.9 Bacterial pneumonia, unspecified	0.000	0.998	0.002
J15.8 Other bacterial pneumonia	0.000	0.998	0.002
J15.7 Pneumonia due to Mycoplasma pneumoniae	0.000	0.998	0.002
J15.6 Pneumonia due to other aerobic Gram-negative bacteria	0.000	0.998	0.002
J15.5 Pneumonia due to Escherichia coli	0.000	0.998	0.002
J15.4 Pneumonia due to other streptococci	0.000	0.998	0.002
J15.3 Pneumonia due to streptococcus, group B	0.000	0.998	0.002
J15.2 Pneumonia due to staphylococcus	0.000	0.998	0.002
J15.1 Pneumonia due to Pseudomonas	0.000	0.998	0.002
J15.0 Pneumonia due to Klebsiella pneumoniae	0.000	0.998	0.002
J16.8 Pneumonia due to other specified infectious organisms	0.000	0.998	0.002
J16.0 Chlamydial pneumonia	0.000	0.998	0.002
J17.8 Pneumonia in other diseases classified elsewhere	0.000	0.998	0.002
J17.3 Pneumonia in parasitic diseases	0.000	0.998	0.002
J17.2 Pneumonia in mycoses	0.000	0.998	0.002
J17.1 Pneumonia in viral diseases classified elsewhere	0.000	0.998	0.002
J17.0 Pneumonia in bacterial diseases classified elsewhere	0.000	0.998	0.002
J38.0 Paralysis of vocal cords and larynx	0.002	0.998	0.000
M75.4 Impingement syndrome of shoulder	0.000	0.998	0.002
M51 Other intervertebral disk disorders	0.002	0.998	0.000
J30.4 Allergic rhinitis, unspecified	0.002	0.998	0.000
J30.3 Other allergic rhinitis	0.002	0.998	0.000
J30.2 Other seasonal allergic rhinitis	0.002	0.998	0.000
J30.0 Vasomotor rhinitis	0.002	0.998	0.000
M54.3 Sciatica	0.002	0.998	0.000
J30-J39 Other diseases of upper respiratory tract	0.002	0.998	0.000
M54 Dorsalgia	0.002	0.998	0.000
M54.50 Low back pain (Multiple sites in spine)	0.002	0.998	0.000
J38.6 Stenosis of larynx	0.002	0.998	0.000
J38.5 Laryngeal spasm	0.002	0.998	0.000
J38.4 Oedema of larynx	0.002	0.998	0.000
J38.2 Nodules of vocal cords	0.002	0.998	0.000
J38.1 Polyp of vocal cord and larynx	0.002	0.998	0.000
M54.56 Low back pain (Lumbar region)	0.002	0.998	0.000
Y43 Primarily systemic agents	0.002	0.998	0.000
J38.7 Other diseases of larynx	0.002	0.998	0.000
J35 Chronic diseases of tonsils and adenoids	0.002	0.998	0.000
C50.4 Upper-outer quadrant of breast	0.002	0.998	0.000
C50.3 Lower-inner quadrant of breast	0.002	0.998	0.000
A08 Viral and other specified intestinal infections	0.000	0.998	0.002
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.002	0.998	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.002	0.998	0.000
E66.8 Other obesity	0.002	0.998	0.000
C50.2 Upper-inner quadrant of breast	0.002	0.998	0.000
J34 Other disorders of nose and nasal sinuses	0.002	0.998	0.000
C50.1 Central portion of breast	0.002	0.998	0.000
C85.1 B-cell lymphoma, unspecified	0.002	0.998	0.000
M54.55 Low back pain (Thoracolumbar region)	0.002	0.998	0.000
M54.54 Low back pain-Thoracic	0.002	0.998	0.000
M54.53 Low back pain-Cervicothoracic	0.002	0.998	0.000
M54.52 Low back pain-Cervical	0.002	0.998	0.000
M54.51 Low back pain-Occipit-atl-axl	0.002	0.998	0.000
J35.0 Chronic tonsillitis	0.002	0.998	0.000
M54.9 Dorsalgia, unspecified	0.002	0.998	0.000
M54.36 Sciatica (Lumbar region)	0.002	0.998	0.000
M06.9 Rheumatoid arthritis, unspecified	0.000	0.998	0.002
Z13.0 Special screening examination for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.000	0.998	0.002
C50.6 Axillary tail of breast	0.002	0.998	0.000
C50.0 Nipple and areola	0.002	0.998	0.000
M51.0 Lumbar and other intervertebral disk disorders with myelopathy	0.002	0.998	0.000
Y57.9 Drug or medicament, unspecified	0.002	0.998	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
M54.38 Sciatica (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M54.37 Sciatica (Lumbosacral region)	0.002	0.998	0.000
M54.35 Sciatica (Thoracolumbar region)	0.002	0.998	0.000
M54.34 Sciatica-Thoracic	0.002	0.998	0.000
M54.33 Sciatica-Cervicothoracic	0.002	0.998	0.000
M54.32 Sciatica-Cervical	0.002	0.998	0.000
M54.31 Sciatica-Occipit-atl-axl	0.002	0.998	0.000
M54.30 Sciatica (Multiple sites in spine)	0.002	0.998	0.000
C44.1 Skin of eyelid, including canthus	0.002	0.998	0.000
J33.8 Other polyp of sinus	0.002	0.998	0.000
M51.3 Other specified intervertebral disk degeneration	0.002	0.998	0.000
M51.1 Lumbar and other intervertebral disk disorders with radiculopathy	0.002	0.998	0.000
M51.9 Intervertebral disk disorder, unspecified	0.002	0.998	0.000
M51.8 Other specified intervertebral disk disorders	0.002	0.998	0.000
M51.4 Schmorl's nodes	0.002	0.998	0.000
M54.4 Lumbago with sciatica	0.002	0.998	0.000
C71 Malignant neoplasm of brain	0.002	0.998	0.000
C71.9 Brain, unspecified	0.002	0.998	0.000
J35.1 Hypertrophy of tonsils	0.002	0.998	0.000
J37 Chronic laryngitis and laryngotracheitis	0.002	0.998	0.000
C71.3 Parietal lobe	0.002	0.998	0.000
C71.2 Temporal lobe	0.002	0.998	0.000
J36 Peritonsillar abscess	0.002	0.998	0.000
G43.9 Migraine, unspecified	0.002	0.998	0.000
M54.8 Other dorsalgia	0.002	0.998	0.000
M54.6 Pain in thoracic spine	0.002	0.998	0.000
M54.0 Panniculitis affecting regions of neck and back	0.002	0.998	0.000
I73 Other peripheral vascular diseases	0.000	0.998	0.002
Y57 Other and unspecified drugs and medicaments	0.002	0.998	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.002	0.998	0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.000	0.998	0.002
M54.99 Dorsalgia, unspecified (Site unspecified)	0.002	0.998	0.000
C50.5 Lower-outer quadrant of breast	0.002	0.998	0.000
C92 Myeloid leukaemia	0.002	0.998	0.000
C50.9 Breast, unspecified	0.002	0.998	0.000
Y43.9 Primarily systemic agent, unspecified	0.002	0.998	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.002	0.998	0.000
Y43.6 Enzymes, not elsewhere classified	0.002	0.998	0.000
Y43.5 Acidifying and alkalising agents	0.002	0.998	0.000
Y43.4 Immunosuppressive agents	0.002	0.998	0.000
Y43.2 Antineoplastic natural products	0.002	0.998	0.000
Y43.1 Antineoplastic antimetabolites	0.002	0.998	0.000
Y43.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
M54.58 Low back pain (Sacral and sacrococcygeal region)	0.002	0.998	0.000
J35.9 Chronic disease of tonsils and adenoids, unspecified	0.002	0.998	0.000
J35.8 Other chronic diseases of tonsils and adenoids	0.002	0.998	0.000
J35.3 Hypertrophy of tonsils with hypertrophy of adenoids	0.002	0.998	0.000
J35.2 Hypertrophy of adenoids	0.002	0.998	0.000
N81.1 Cystocele	0.002	0.998	0.000
J33 Nasal polyp	0.002	0.998	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.002	0.998	0.000
K30 Dyspepsia	0.000	0.998	0.002
A08.5 Other specified intestinal infections	0.000	0.998	0.002
A08.3 Other viral enteritis	0.000	0.998	0.002
A08.2 Adenoviral enteritis	0.000	0.998	0.002
A08.1 Acute gastro-enteropathy due to Norwalk agent	0.000	0.998	0.002
A08.0 Rotaviral enteritis	0.000	0.998	0.002
C85.7 Other specified types of non-Hodgkin's lymphoma	0.002	0.998	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.002	0.998	0.000
C85.0 Lymphosarcoma	0.002	0.998	0.000
I63.9 Cerebral infarction, unspecified	0.000	0.998	0.002
C92.1 Chronic myeloid leukaemia	0.002	0.998	0.000
J39 Other diseases of upper respiratory tract	0.002	0.998	0.000
J34.1 Cyst and mucocele of nose and nasal sinus	0.002	0.998	0.000
J34.0 Abscess, furuncle and carbuncle of nose	0.002	0.998	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.002	0.998	0.000
J31 Chronic rhinitis, nasopharyngitis and pharyngitis	0.002	0.998	0.000
M50-M54 Other dorsopathies	0.002	0.998	0.000
M54.1 Radiculopathy	0.002	0.998	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.002	0.998	0.000
M54.98 Dorsalgia, unspecified (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M54.97 Dorsalgia, unspecified (Lumbosacral region)	0.002	0.998	0.000
M54.96 Dorsalgia, unspecified (Lumbar region)	0.002	0.998	0.000
M54.95 Dorsalgia, unspecified (Thoracolumbar region)	0.002	0.998	0.000
M54.94 Dorsalgia, unspecified (Thoracic region)	0.002	0.998	0.000
M54.93 Dorsalgia, unspecified (Cervicothoracic region)	0.002	0.998	0.000
M54.92 Dorsalgia, unspecified (Cervical region)	0.002	0.998	0.000
M54.91 Dorsalgia, unspecified (Occipito-atlanto-axial region)	0.002	0.998	0.000
M54.90 Dorsalgia, unspecified (Multiple sites in spine)	0.002	0.998	0.000
C83.3 Large cell (diffuse)	0.002	0.998	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
A09.9 Gastroenteritis and colitis of unspecified origin	0.000	0.998	0.002
C91 Lymphoid leukaemia	0.002	0.998	0.000
M54.46 Lumbago with sciatica (Lumbar region)	0.002	0.998	0.000
J34.2 Deviated nasal septum	0.002	0.998	0.000
M06.98 Rheumatoid arthritis, unspecified (Other)	0.000	0.998	0.002
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.000	0.998	0.002
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.000	0.998	0.002
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.000	0.998	0.002
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.000	0.998	0.002
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.000	0.998	0.002
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.000	0.998	0.002
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.000	0.998	0.002
M54.57 Low back pain (Lumbosacral region)	0.002	0.998	0.000
Y54.3 Benzothiadiazine derivatives	0.002	0.998	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.002	0.998	0.000
C81 Hodgkin's disease	0.002	0.998	0.000
Y44 Agents primarily affecting blood constituents	0.002	0.998	0.000
M51.19 Lumbar and other intervertebral disc disorders with radiculopathy; site unspecified	0.001	0.998	0.000
M51.16 Intervertebral disc disorders w radiculopathy, lumbar region	0.001	0.998	0.000
M51.37 Other intervertebral disc degeneration, lumbosacral region	0.001	0.998	0.000
M54.49 Lumbago with sciatica (Site unspecified)	0.001	0.998	0.000
M54.48 Lumbago with sciatica (Sacral and sacrococcygeal region)	0.001	0.998	0.000
M54.47 Lumbago with sciatica (Lumbosacral region)	0.001	0.998	0.000
M54.45 Lumbago with sciatica (Thoracolumbar region)	0.001	0.998	0.000
M54.44 Lumbago with sciatica-Thoracic	0.001	0.998	0.000
M54.43 Lumbago with sciatica-Cervicothoracic	0.001	0.998	0.000
M54.42 Lumbago with sciatica-Cervical	0.001	0.998	0.000
M54.41 Lumbago with sciatica-Occipit-atl-axl	0.001	0.998	0.000
M54.40 Lumbago with sciatica (Multiple sites in spine)	0.001	0.998	0.000
C71.8 Overlapping lesion of brain	0.002	0.998	0.000
C71.7 Brain stem	0.002	0.998	0.000
C71.6 Cerebellum	0.002	0.998	0.000
C71.5 Cerebral ventricle	0.002	0.998	0.000
C71.4 Occipital lobe	0.002	0.998	0.000
C71.1 Frontal lobe	0.002	0.998	0.000
C71.0 Cerebrum, except lobes and ventricles	0.002	0.998	0.000
J84.1 Other interstitial pulmonary diseases with fibrosis	0.002	0.998	0.000
M54.2 Cervicalgia	0.002	0.998	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
C95 Leukaemia of unspecified cell type	0.002	0.998	0.000
C94 Other leukaemias of specified cell type	0.002	0.998	0.000
C93 Monocytic leukaemia	0.002	0.998	0.000
C88 Malignant immunoproliferative diseases	0.002	0.998	0.000
C86 Other specified types of T/NK-cell lymphoma	0.002	0.998	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.002	0.998	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
M81.99 Osteoporosis, unspecified (Site unspecified)	0.000	0.998	0.002
C90.0 Multiple myeloma	0.002	0.998	0.000
J37.1 Chronic laryngotracheitis	0.001	0.998	0.000
J37.0 Chronic laryngitis	0.001	0.998	0.000
Y52 Agents primarily affecting the cardiovascular system	0.002	0.998	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.002	0.998	0.000
C50-C50 Malignant neoplasm of breast	0.002	0.998	0.000
M54.09 Panniculitis affecting regions of neck and back (Site unspecified)	0.001	0.998	0.000
M54.08 Panniculitis affecting regions of neck and back (Sacral and sacrococcygeal region)	0.001	0.998	0.000
M54.07 Panniculitis affecting regions of neck and back (Lumbosacral region)	0.001	0.998	0.000
M54.06 Panniculitis affecting regions of neck and back (Lumbar region)	0.001	0.998	0.000
M54.05 Panniculitis affecting regions of neck and back (Thoracolumbar region)	0.001	0.998	0.000
M54.04 Panniculitis affecting regions of neck and back (Thoracic region)	0.001	0.998	0.000
M54.03 Panniculitis affecting regions of neck and back (Cervicothoracic region)	0.001	0.998	0.000
M54.02 Panniculitis affecting regions of neck and back (Cervical region)	0.001	0.998	0.000
M54.01 Panniculitis affecting regions of neck and back (Occipito-atlanto-axial region)	0.001	0.998	0.000
M54.00 Panniculitis affecting regions of neck and back (Multiple sites in spine)	0.001	0.998	0.000
M54.69 Pain in thoracic spine-Site unspe	0.001	0.998	0.000
M54.68 Pain in thoracic spine-Sacral/sacrococ	0.001	0.998	0.000
M54.67 Pain in thoracic spine-Lumbosacral	0.001	0.998	0.000
M54.66 Pain in thoracic spine-Lumbar	0.001	0.998	0.000
M54.65 Pain in thoracic spine (Thoracolumbar region)	0.001	0.998	0.000
M54.64 Pain in thoracic spine (Thoracic region)	0.001	0.998	0.000
M54.63 Pain in thoracic spine (Cervicothoracic region)	0.001	0.998	0.000
M54.62 Pain in thoracic spine-Cervical	0.001	0.998	0.000
M54.61 Pain in thoracic spine-Occipit-atl-axl	0.001	0.998	0.000
M54.60 Pain in thoracic spine (Multiple sites in spine)	0.001	0.998	0.000
M54.89 Other dorsalgia (Site unspecified)	0.001	0.998	0.000
M54.88 Other dorsalgia (Sacral and sacrococcygeal region)	0.001	0.998	0.000
M54.87 Other dorsalgia (Lumbosacral region)	0.001	0.998	0.000
M54.86 Other dorsalgia (Lumbar region)	0.001	0.998	0.000
M54.85 Other dorsalgia (Thoracolumbar region)	0.001	0.998	0.000
M54.84 Other dorsalgia (Thoracic region)	0.001	0.998	0.000
M54.83 Other dorsalgia (Cervicothoracic region)	0.001	0.998	0.000
M54.82 Other dorsalgia (Cervical region)	0.001	0.998	0.000
M54.81 Other dorsalgia (Occipito-atlanto-axial region)	0.001	0.998	0.000
M54.80 Other dorsalgia (Multiple sites in spine)	0.001	0.998	0.000
Y57.8 Other drugs and medicaments	0.001	0.998	0.000
Y57.7 Vitamins, not elsewhere classified	0.001	0.998	0.000
Y57.6 Other diagnostic agents	0.001	0.998	0.000
Y57.5 X-ray contrast media	0.001	0.998	0.000
Y57.4 Pharmaceutical excipients	0.001	0.998	0.000
Y57.3 Alcohol deterrents	0.001	0.998	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.001	0.998	0.000
Y57.1 Lipotropic drugs	0.001	0.998	0.000
Y57.0 Appetite depressants [anorectics]	0.001	0.998	0.000
C44.2 Skin of ear and external auricular canal	0.002	0.998	0.000
C92.0 Acute myeloid leukaemia	0.001	0.998	0.000
I73.8 Other specified peripheral vascular diseases	0.000	0.998	0.001
I73.1 Thromboangiitis obliterans [Buerger]	0.000	0.998	0.001
Y45.0 Opioids and related analgesics	0.002	0.998	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
R21 Rash and other nonspecific skin eruption	0.002	0.998	0.000
Y59 Other and unspecified vaccines and biological substances	0.001	0.998	0.000
Y58 Bacterial vaccines	0.001	0.998	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.001	0.998	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.001	0.998	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.001	0.998	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.001	0.998	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.001	0.998	0.000
Y48 Anaesthetics and therapeutic gases	0.001	0.998	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.001	0.998	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.001	0.998	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.001	0.998	0.000
C92.9 Myeloid leukaemia, unspecified	0.001	0.998	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.001	0.998	0.000
C92.7 Other myeloid leukaemia	0.001	0.998	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.001	0.998	0.000
C92.5 Acute myelomonocytic leukaemia	0.001	0.998	0.000
C92.4 Acute promyelocytic leukaemia	0.001	0.998	0.000
C92.3 Myeloid sarcoma	0.001	0.998	0.000
C92.2 Subacute myeloid leukaemia	0.001	0.998	0.000
I73.0 Raynaud's syndrome	0.000	0.998	0.002
C44 Other malignant neoplasms of skin	0.002	0.998	0.000
J90-J94 Other diseases of pleura	0.000	0.998	0.001
J33.1 Polypoid sinus degeneration	0.001	0.998	0.000
J39.8 Other specified diseases of upper respiratory tract	0.001	0.998	0.000
J93.9 Pneumothorax, unspecified	0.000	0.998	0.001
J93 Pneumothorax	0.000	0.998	0.001
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.001	0.998	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.001	0.998	0.000
C83.7 Burkitt's tumour	0.001	0.998	0.000
C83.6 Undifferentiated (diffuse)	0.001	0.998	0.000
C83.5 Lymphoblastic (diffuse)	0.001	0.998	0.000
C83.4 Immunoblastic (diffuse)	0.001	0.998	0.000
C83.2 Mixed small and large cell (diffuse)	0.001	0.998	0.000
C83.1 Small cleaved cell (diffuse)	0.001	0.998	0.000
C83.0 Small cell (diffuse)	0.001	0.998	0.000
K13.7 Other and unspecified lesions of oral mucosa	0.002	0.998	0.000
H25 Senile cataract	0.002	0.998	0.000
J39.9 Disease of upper respiratory tract, unspecified	0.001	0.998	0.000
J39.3 Upper respiratory tract hypersensitivity reaction, site unspecified	0.001	0.998	0.000
J39.1 Other abscess of pharynx	0.001	0.998	0.000
J39.0 Retropharyngeal and parapharyngeal abscess	0.001	0.998	0.000
A09 Diarrhoea and gastro-enteritis of presumed infectious origin	0.000	0.998	0.002
Y40 Systemic antibiotics	0.001	0.998	0.000
C90.3 Solitary plasmacytoma	0.001	0.998	0.000
C90.2 Plasmacytoma, extramedullary	0.001	0.998	0.000
C90.1 Plasma cell leukaemia	0.001	0.998	0.000
J31.2 Chronic pharyngitis	0.001	0.998	0.000
J31.1 Chronic nasopharyngitis	0.001	0.998	0.000
M53 Other dorsopathies, not elsewhere classified	0.001	0.998	0.000
M54.19 Radiculopathy (Site unspecified)	0.001	0.998	0.000
M54.18 Radiculopathy (Sacral and sacrococcygeal region)	0.001	0.998	0.000
M54.17 Radiculopathy (Lumbosacral region)	0.001	0.998	0.000
M54.15 Radiculopathy (Thoracolumbar region)	0.001	0.998	0.000
M54.14 Radiculopathy (Thoracic region)	0.001	0.998	0.000
M54.13 Radiculopathy (Cervicothoracic region)	0.001	0.998	0.000
M54.12 Radiculopathy (Cervical region)	0.001	0.998	0.000
M54.11 Radiculopathy (Occipito-atlanto-axial region)	0.001	0.998	0.000
M54.10 Radiculopathy (Multiple sites in spine)	0.001	0.998	0.000
C91.1 Chronic lymphocytic leukaemia	0.001	0.998	0.000
Y44.2 Anticoagulants	0.001	0.998	0.000
Y54.9 Mineral salts, not elsewhere classified	0.001	0.998	0.000
Y54.8 Agents affecting uric acid metabolism	0.001	0.998	0.000
Y54.7 Agents affecting calcification	0.001	0.998	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.001	0.998	0.000
Y54.5 Other diuretics	0.001	0.998	0.000
Y54.4 Loop [high-ceiling] diuretics	0.001	0.998	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.001	0.998	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.001	0.998	0.000
Y54.0 Mineralocorticoids	0.001	0.998	0.000
J84.9 Interstitial pulmonary disease, unspecified	0.001	0.998	0.000
M75.0 Adhesive capsulitis of shoulder	0.000	0.998	0.002
R19.5 Other fecal abnormalities	0.000	0.998	0.002
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.001	0.998	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.001	0.998	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.001	0.998	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.001	0.998	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.001	0.998	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.001	0.998	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.001	0.998	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.001	0.998	0.000
Y51.0 Anticholinesterase agents	0.001	0.998	0.000
W19 Unspecified fall	0.000	0.998	0.001
C91.9 Lymphoid leukaemia, unspecified	0.001	0.998	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.001	0.998	0.000
C91.7 Other lymphoid leukaemia	0.001	0.998	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.001	0.998	0.000
C91.5 Adult T-cell leukaemia	0.001	0.998	0.000
C91.4 Hairy-cell leukaemia	0.001	0.998	0.000
C91.3 Prolymphocytic leukaemia	0.001	0.998	0.000
C91.2 Subacute lymphocytic leukaemia	0.001	0.998	0.000
C91.0 Acute lymphoblastic leukaemia	0.001	0.998	0.000
J33.0 Polyp of nasal cavity	0.001	0.998	0.000
R00.0 Tachycardia, unspecified	0.000	0.998	0.002
C81.9 Hodgkin's disease, unspecified	0.001	0.998	0.000
C81.7 Other Hodgkin's disease	0.001	0.998	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.001	0.998	0.000
C81.3 Lymphocytic depletion	0.001	0.998	0.000
C81.2 Mixed cellularity	0.001	0.998	0.000
C81.1 Nodular sclerosis	0.001	0.998	0.000
C81.0 Lymphocytic predominance	0.001	0.998	0.000
Y42.5 Other oestrogens and progestogens	0.001	0.998	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.001	0.998	0.000
M54.29 Cervicalgia-Site unspe	0.001	0.998	0.000
M54.28 Cervicalgia-Sacral/sacrococ	0.001	0.998	0.000
M54.27 Cervicalgia-Lumbosacral	0.001	0.998	0.000
M54.26 Cervicalgia-Lumbar	0.001	0.998	0.000
M54.25 Cervicalgia-Thoracolumbar	0.001	0.998	0.000
M54.24 Cervicalgia-Thoracic	0.001	0.998	0.000
M54.23 Cervicalgia (Cervicothoracic region)	0.001	0.998	0.000
M54.21 Cervicalgia (Occipito-atlanto-axial region)	0.001	0.998	0.000
M54.20 Cervicalgia-Mult site	0.001	0.998	0.000
A04.8 Other specified bacterial intestinal infections	0.000	0.998	0.001
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.001	0.998	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.001	0.998	0.000
C82.6 Cutaneous follicle centre lymphoma	0.001	0.998	0.000
C82.5 Diffuse follicle centre lymphoma	0.001	0.998	0.000
C82.4 Follicular lymphoma grade IIIb	0.001	0.998	0.000
C82.3 Follicular lymphoma grade IIIa	0.001	0.998	0.000
C82.2 Large cell, follicular	0.001	0.998	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.001	0.998	0.000
C82.0 Small cleaved cell, follicular	0.001	0.998	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.001	0.998	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.001	0.998	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.001	0.998	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.001	0.998	0.000
C84.5 Other and unspecified T-cell lymphomas	0.001	0.998	0.000
C84.4 Peripheral T-cell lymphoma	0.001	0.998	0.000
C84.3 Lymphoepithelioid lymphoma	0.001	0.998	0.000
C84.2 T-zone lymphoma	0.001	0.998	0.000
C84.1 Sezary's diease	0.001	0.998	0.000
C84.0 Mycosis fungoides	0.001	0.998	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.001	0.998	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.001	0.998	0.000
C86.4 Blastic NK-cell lymphoma	0.001	0.998	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.001	0.998	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.001	0.998	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.001	0.998	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.001	0.998	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.001	0.998	0.000
C88.7 Other malignant immunoproliferative diseases	0.001	0.998	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.001	0.998	0.000
C88.3 Immunoproliferative small intestinal disease	0.001	0.998	0.000
C88.2 Gamma heavy chain disease	0.001	0.998	0.000
C88.1 Alpha heavy chain disease	0.001	0.998	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.001	0.998	0.000
C93.9 Monocytic leukaemia, unspecified	0.001	0.998	0.000
C93.7 Other monocytic leukaemia	0.001	0.998	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.001	0.998	0.000
C93.2 Subacute monocytic leukaemia	0.001	0.998	0.000
C93.1 Chronic monocytic leukaemia	0.001	0.998	0.000
C93.0 Acute monocytic leukaemia	0.001	0.998	0.000
C94.7 Other specified leukaemias	0.001	0.998	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.001	0.998	0.000
C94.5 Acute myelofibrosis	0.001	0.998	0.000
C94.4 Acute panmyelosis	0.001	0.998	0.000
C94.3 Mast cell leukaemia	0.001	0.998	0.000
C94.2 Acute megakaryoblastic leukaemia	0.001	0.998	0.000
C94.1 Chronic erythraemia	0.001	0.998	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.001	0.998	0.000
C95.9 Leukaemia, unspecified	0.001	0.998	0.000
C95.7 Other leukaemia of unspecified cell type	0.001	0.998	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.001	0.998	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.001	0.998	0.000
C95.0 Acute leukaemia of unspecified cell type	0.001	0.998	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.001	0.998	0.000
C96.8 Histiocytic sarcoma	0.001	0.998	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.001	0.998	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.001	0.998	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.001	0.998	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.001	0.998	0.000
C96.3 True histiocytic lymphoma	0.001	0.998	0.000
C96.2 Malignant mast cell tumour	0.001	0.998	0.000
C96.1 Malignant histiocytosis	0.001	0.998	0.000
C96.0 Letterer-Siwe disease	0.001	0.998	0.000
Y42.9 Other and unspecified hormone antagonists	0.001	0.998	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.001	0.998	0.000
Y42.7 Androgens and anabolic congeners	0.001	0.998	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.001	0.998	0.000
Y42.4 Oral contraceptives	0.001	0.998	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.001	0.998	0.000
Y42.2 Antithyroid drugs	0.001	0.998	0.000
Y42.1 Thyroid hormones and substitutes	0.001	0.998	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.001	0.998	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.001	0.998	0.000
Y44.7 Plasma substitutes	0.001	0.998	0.000
Y44.6 Natural blood and blood products	0.001	0.998	0.000
Y44.5 Thrombolytic drugs	0.001	0.998	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.001	0.998	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.001	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.001	0.998	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.001	0.998	0.000
J32 Chronic sinusitis	0.001	0.998	0.000
J84 Other interstitial pulmonary diseases	0.001	0.998	0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.001	0.998	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.001	0.999	0.000
Y45.8 Other analgesics and antipyretics	0.001	0.999	0.000
Y45.5 4-Aminophenol derivatives	0.001	0.999	0.000
Y45.4 Antirheumatics	0.001	0.999	0.000
Y45.2 Propionic acid derivatives	0.001	0.999	0.000
Y45.1 Salicylates	0.001	0.999	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.001	0.999	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.001	0.999	0.000
Y52.7 Peripheral vasodilators	0.001	0.999	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.001	0.999	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.001	0.999	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.001	0.999	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.001	0.999	0.000
Y52.1 Calcium-channel blockers	0.001	0.999	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.001	0.999	0.000
C44.3 Skin of other and unspecified parts of face	0.001	0.999	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations